ANN ARBOR - October 31 is the last day to receive early-bird pricing for attending the MichBio Expo, which takes place on November 18-19 at the Rock Financial ShowPlace in Novi. It is the 4th Annual Expo presented by MichBio, the association for the biosciences industry in Michigan. Exhibit booth prices also go up Nov.
ROCHESTER - Oakland University will host Stem Cell Research: The Science, the Cures and the Law, an informational conference Oct. 28 at the Oakland Center Banquet Rooms. The forum will be led by Marcia Baum, executive director of Michigan Citizens for Stem Cell Research and Cures, from 6:30-8:30 p.m.. A question and answer session featuring
DETROIT - Susan G. Komen for the Cure has announced the distribution of an unprecedented $100 million in grants to American and international scientists this year to fast track breast cancer research, including three grants worth more than $900,000 given to two Wayne State University researchers. Two researchers from the Barbara Ann Karmanos Cancer Institute
LANSING - Supporters of Proposal 2008-2 denounced as a lie a new television ad from opponents, which charges that allowing expanded embryonic stem cell research in the state would lead to corporate exploitation of the research. "They simply are not telling the truth," said former U.S. Rep. Joe Schwarz, chair of the MiCure campaign. "I
ALLEGAN - Perrigo Company announced Monday that it has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, privately-held Laboratorios Diba is a store brand manufacturer of over-the-counter and prescription pharmaceuticals, including antibiotics, hormonals and opthalmics. The acquisition is expected to add nearly $15 million of annual sales. "Perrigo has
LANSING - The first ad on November ballot proposals hit the airwaves Tuesday with opponents of Proposal 2008-2 arguing the plan to allow embryonic stem cell research in the state will mean more costs to taxpayers. If the election were held Tuesday, a majority of voters would support a proposal expanding the use of embryonic
GRAND RAPIDS - Van Andel Institute researchers have determined the molecular structure of a nuclear receptor, which regulates the expression of specific genes within cells, which may serve as a drug target for diseases related to heart and blood vessel development, human embryonic development and female infertility. Researchers also found that the receptor, named COUP-TFII,
SOUTHFIELD - Jeffery Kocsis has been named to receive the da Vinci Lifetime Achievement Award from the National Multiple Sclerosis Society, Michigan Chapter for his work with new treatment strategies for people with MS. Kocsis received his Ph.D. in 1976 from Wayne State University and has a long history of research and publications on transplantation-based
DETROIT �?? The Barbara Ann Karmanos Cancer Institute�??s National Oncogenomics and Molecular Imaging Center will soon get a $4,672,000 in federal appropriations from the U.S. Army to help develop technology that will allow for the diagnosis of human cancer by defining oncogene signatures that characterize cancers in individual patients. The federal funding, which will be
GRAND RAPIDS - Researchers at Van Andel Institute and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival, which could help lead to more effective treatment of pancreatic, prostate and lung cancers. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of